|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest-bearing deposits at other financial institutions | ||||||||||||||||||||
| Federal funds sold | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Investment securities available-for-sale (AFS), at fair value | ||||||||||||||||||||
| Investment securities held-to-maturity (HTM), at amortized cost, net of allowance for credit losses of $0 and $0, respectively | ||||||||||||||||||||
| Restricted securities, at amortized cost | ||||||||||||||||||||
| Loans, net of allowance for credit losses of $19,306 and $19,308, respectively | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Property held for sale, at fair value | ||||||||||||||||||||
| Other real estate owned, net | ||||||||||||||||||||
| Accrued interest and other receivables | ||||||||||||||||||||
| Computer software, net of amortization | ||||||||||||||||||||
| Bank owned life insurance | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Non-interest bearing demand deposits | ||||||||||||||||||||
| Interest-bearing demand deposits | ||||||||||||||||||||
| Savings and NOW deposits | ||||||||||||||||||||
| Money market deposits | ||||||||||||||||||||
| Time deposits | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Federal funds purchased | ||||||||||||||||||||
| Federal Home Loan Bank advances | ||||||||||||||||||||
| Subordinated debt, net | ||||||||||||||||||||
| Allowance for credit losses on off-balance sheet credit exposure | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Stockholders’ Equity | ||||||||||||||||||||
| Preferred stock, $1.00 par value, 2,000,000 shares authorized; 28,750 shares issued and outstanding at June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Common stock, $4.00 par value, 15,000,000 shares authorized; issued and outstanding 7,117,438 shares (including 259,985 nonvested shares) at June 30, 2026 and 7,496,571 shares (including 244,964 nonvested shares) at December 31, 2025 | ||||||||||||||||||||
| Capital surplus | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total Stockholders’ Equity | ||||||||||||||||||||
| Total Liabilities and Stockholders’ Equity | ||||||||||||||||||||
Loading...
